FDA updates COVID-19 vaccine warnings on heart inflammation risks

FDA updates COVID-19 vaccine warnings on heart inflammation risks

Publication date: Jul 01, 2025

Some participants reported persistent heart symptoms approximately three months after their myocarditis diagnosis. The study found that persistence of abnormal cardiac MRI findings, a marker for myocardial injury, was common at a median follow-up of approximately five months post-vaccination. The long-term clinical significance of these MRI findings is currently unknown. Information about myocarditis and pericarditis has been included in the vaccine labeling since 2021. Initial and follow-up cardiac MRIs in some individuals commonly showed signs of heart muscle injury, with some improvement over time, but not in all cases.

Concepts Keywords
Cardiac Cardiac
Fda Covid
Food Fda
Myocarditis Findings
Follow
Heart
Individuals
Inflammation
Mri
Mrna
Myocarditis
Pericarditis
Vaccine
Vaccines
Warnings

Semantics

Type Source Name
disease MESH inflammation
disease MESH myocarditis
disease MESH pericarditis
disease MESH clinical significance

Original Article

(Visited 2 times, 1 visits today)